Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.
|Tekcapital investee Belluscura eyes raising GBP17.5 million in AIM IPO
|Intention to float - AIM
London Stock Exchange
|Medical device firm Belluscura has revealed plans for a London float
|Belluscur plans London float
|Acquisition for medical device company